CRONCronos Group Inc.
$3.23+23% 1Y
$3.23
$2.3052 weeks$3.55
The financials
Cronos Group Inc. by the numbers
Cronos Group Inc. (CRON) reported revenue of $53M in Q2 2026 (quarter ended Jun 30, 2026), up 58% from the same quarter a year earlier. That came with a gross margin of 54% and net income of $32M (61% of revenue). For the full year FY2025, revenue was $147M (+25% year on year) and net income −$9.4M. Its largest region in Q2 2026 was Canada at $29M, 54% of the disclosed total, well ahead of Israel at 28%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $53M | $33M | +58% |
| Gross profit | $28M | $15M | +96% |
| Operating income | $7.4M | −$5.3M | to a profit |
| Net income | $32M | −$40M | to a profit |
| Diluted EPS | $0.09 | −$0.10 | to a profit |
| Geographic | Revenue | Share |
|---|---|---|
| Canada | $29M | 54% |
| Israel | $15M | 28% |
| Other Countries | $9.3M | 18% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $53.0M (+17%)
Other Countries grew +88% year on yearCanada +50% year on year
Segment Latestquarter on quarteryear on year
- Canada$28.7M$28.7Mquarter on quarter +13%year on year +50%+13%+50%
- Israel$15.0M$15.0Mquarter on quarter +6.1%year on year +60%+6.1%+60%
- Other Countries$9.3M$9.3Mquarter on quarter +63%year on year +88%+63%+88%
Drug Manufacturers, Specialty & Generic
Ranks #33 of 41 by RyuScore